My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 1 Trial

Recent news which mentions Phase 1 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
Tickers GSK LYEL
Tags Briefs Biotech Benzinga
From Benzinga
FDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies
Tickers TCRX
Tags Market News News FDA
From Benzinga
Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers
Tickers HCWB
Tags General Phase 1 Trial Market News
From Benzinga
Regulus Therapeutics Moves Forward With Next-Gen Compound, RGLS8429 In Kidney Disorder
Tickers RGLS
Tags FDA News Market News
From Benzinga
FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
Tickers KURA
Tags Phase 1 Trial acute myeloid leukemia General
From Benzinga
FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
Tickers EQRX TPTX
Tags Health Care Movers Biotechnology
From Benzinga
FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors
Tickers NUVB
Tags Small Cap Health Care Biotech
From Benzinga
Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer
Tickers MRK SGEN
Tags General SGEN Benzinga
From Benzinga
Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer
Tickers CRDF
Tags General CRDF Phase 1 Trial
From Benzinga
Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
Tickers PCVX
Tags Benzinga Briefs Biotech
From Benzinga
French Regulatory Authority Gives Green Signal To Phio Pharma's Melanoma Trial
Tickers PHIO
Tags Benzinga Long Ideas Penny Stocks
From Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
Tickers GLMD
Tags ulcerative colitis Market News News
From Benzinga
Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study
Tickers AVXL
Tags Small Cap News AVXL
From Benzinga
Edgewise Therapeutics Shares Jump After Positive Data On Becker Muscular Dystrophy Study
Tickers EWTX
Tags EWTX Market News why it's moving
From Benzinga
Inhibrx Shares Interim Data On INBRX-106 - Keytruda Combo Therapy In Solid Tumors
Tickers INBX
Tags Benzinga General Phase 1 Trial
From Benzinga
Equillium To Reassess Potential For Its Asthma Trials
Tickers EQ
Tags Health Care EQ Trading Ideas
From Benzinga
Gritstone Bio's COVID-19 Booster Dose Shows Early Neutralizing Antibody Responses
Tickers AZN GRTS
Tags COVID/19 Coronavirus GRTS Health Care
From Benzinga
Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
Tickers MREO
Tags Market News Phase 2 Trial News
From Benzinga
Cocrystal's COVID-19 Antiviral Candidate Shows Potency Against Omicron Variant
Tickers COCP
Tags Phase 1 Trial General News
From Benzinga
Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
Tickers ALZN
Tags Trading Ideas Movers Alzheimer's disease
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Tickers QURE
Tags Huntington's Disease Health Care Movers
From Benzinga
Arcturus Shares Shoot Higher After Additional Data From COVID-19 Vaccine Programs
Tickers ARCT BNTX PFE
Tags Long Ideas Biotech Briefs
From Benzinga
IN8bio Stock Jumps After An Update From Leukemia Trial
Tickers INAB
Tags Health Care Movers Trading Ideas
From Benzinga
Cullinan Oncology Posts Updated Data for CLN-081 in NSCLC EGFR Exon 20 Patients
Tickers CGEM
Tags Biotech Briefs Benzinga
From Benzinga
Kymera Discloses New Development Cancer Program
Tickers KYMR
Tags Benzinga KYMR General
From Benzinga
Global Blood Raises $300M Via Convertible Debt Offering
Tickers GBT
Tags Briefs Biotech Sickle Cell Disease
From Benzinga
Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients
Tickers PGEN
Tags Market News News PGEN
From Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
Tickers APTO
Tags Health Care ASH21 Trading Ideas
From Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
Tickers FATE
Tags Biotech FATE Briefs
From Benzinga
Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
Tickers SNDX
Tags News Market News SNDX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.